Trump Secured Two Wins on Election Night
After Kamala Got Trounced by Trump, Dems Have Begun 'Clawing Each Others' Eyes...
We Won and We Need to Act Like It
Obama Reacts to Trump's Shellacking of Kamala Harris
Democrats Have Learned Nothing, Maybe They’re Too Stupid Too
Behold the Press As They Go Through Eight Stages of Grief Regarding the...
Democracy Lives in Brightness
It Would Be Hard to Imagine a More Miserable Day for Democrats
Election 2024: The Revenge of the 'Fascist'
Postmortem 2024
Hispanic Americans and Black Men Got the Message, Contributing to Trump's Victory
How the Democrats' Most Corrupt Reacted to Trump's Win
Trump Gains Another Win With Arizona
Democrats Blame Everything and Everyone for Kamala's Loss-- But Her
Watch Jon Stewart Have a Meltdown Over Trump's Win
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement